Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 3/2016

Open Access 01-06-2016

The Cognitive Symptom Checklist-Work in cancer patients is related with work functioning, fatigue and depressive symptoms: a validation study

Authors: H. F. Dorland, F. I. Abma, C. A. M. Roelen, A. Smink, M. Feuerstein, B. C. Amick, A. V. Ranchor, U. Bültmann

Published in: Journal of Cancer Survivorship | Issue 3/2016

Login to get access

Abstract

Purpose

The study objectives are to translate the 21-item Cognitive Symptom Checklist-Work (CSC-W21) to Dutch (CSC-W DV) and to validate the CSC-W DV in working cancer patients.

Methods

The CSC-W21 was cross-culturally translated and adapted to a Dutch version. In this 19-item version, the dichotomous response option was changed to an ordinal five-point scale. A validation study of the CSC-W DV was conducted among cancer patients who had returned to work during or following cancer treatment. Internal consistency (Cronbach’s α), structural validity (exploratory factor analysis) and construct validity (hypothesis testing) were evaluated.

Results

In a cohort of 364 cancer patients, 341 (94 %) completed the CSC-W DV (aged 50.6 ± 8.6 years, 60 % women). Exploratory factor analysis revealed two subscales ‘working memory’ and ‘executive function’. The internal consistency of the total scale and subscales was high (Cronbach’s α = 0.93–0.95). Hypothesis testing showed that self-reported cognitive limitations at work were related to work functioning (P < 0.001), fatigue (P = 0.001) and depressive symptoms (P < 0.001), but not to self-rated health (P = 0.14).

Conclusions

The CSC-W DV showed high internal consistency and reasonable construct validity for measuring work-specific cognitive symptoms in cancer patients. The CSC-W DV was associated in expected ways with work functioning, fatigue and depressive symptoms.

Implications for Cancer Survivors

It is important to enhance knowledge about cognitive symptoms at work in cancer patients, to guide and support cancer patients as good as possible when they are back at work and to improve their work functioning over time.
Literature
1.
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman D, et al. Survivorship: cognitive function, version 1.2014. J Natl Compr Canc Netw. 2014;12:976–86.PubMedPubMedCentral
2.
Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30.CrossRefPubMed
3.
Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3:223–32.CrossRefPubMedPubMedCentral
4.
Vardy J, Dhillon HM, Pond GR, Xu W, Rourke SB, Dodd A, et al. Cognitive function and fatigue after diagnosis of colorectal cancer. Ann Oncol. 2014;25:2404–12.CrossRefPubMedPubMedCentral
5.
Valentine AD, Meyers CA. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer. 2001;92:1694–8.CrossRefPubMed
6.
Li J, Yu L, Long Z, Li Y, Cao F. Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue. Psychooncology. 2015;24(6):676–82.CrossRefPubMed
7.
Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292–9.CrossRefPubMed
8.
Von Ah D, Habermann B, Carpenter JS, Schnieder B. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013;17:236–41.
9.
Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women’s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs. 2010;19:1362–70.CrossRefPubMed
10.
Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52:219–27.CrossRefPubMed
11.
Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97:958–65.CrossRefPubMed
12.
Feuerstein M, Todd B, Moskowitz M, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4:415–37.CrossRefPubMed
13.
Tannock IF, Ahles TA, Ganz PA, Van Dam F. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22:2233–9.CrossRefPubMed
14.
Wagner LI, Sweet J, Butt Z, Lai JS, Cella D. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009;7:W32–9.
15.
O'hara C, Harrell M, Bellingrath E, Lisicia K. Cognitive symptom checklists: clinician’s guide. Odessa: Psychological Assessment Resources; 1993.
16.
Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG. Work productivity in brain tumor survivors. J Occup Environ Med. 2007;49:803–11.CrossRefPubMed
17.
Ottati A, Feuerstein M. Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv. 2013;7:262–73.CrossRefPubMed
18.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:1417–32.CrossRefPubMed
19.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186–91.CrossRefPubMed
20.
Cheng A, Zeng Y, Feuerstein M. Validation of the Chinese version of the Cognitive Symptom Checklist-Work-21 in breast cancer survivors. J Occup Rehabil Published Online First: 25 March 2015. Doi: 10.​1007/​S10926-015-9576-3
21.
Mokkink LB, Terwee CB, Patrick D, Alonso J, Stratford PW, Knol D, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539–49.CrossRefPubMedPubMedCentral
22.
Mokkink LB, Terwee CB, Knol D, Stratford PW, Alonso J, Patrick D, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22–9.CrossRefPubMedPubMedCentral
23.
Mokkink LB, Terwee CB, Patrick D, Alonso J, Stratford PW, Knol D, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45.CrossRefPubMed
24.
De Vet HCW, Terwee CB, Mokkink LB, Knol DI. Measurement in medicine, practical guides to biostatistics and epidemiology. New York: Cambridge University Press; 2011.
25.
Abma FI, Van Der Klink JJL, Bültmann U. The Work Role Functioning Questionnaire 2.0 (Dutch version): examination of its reliability, validity and responsiveness in the general working population. J Occup Rehabil. 2013;23:135–47.CrossRefPubMed
26.
Amick BC, Lerner D, Rogers WH, Rooney T, Katz JN. A review of health-related work outcome measures and their uses, and recommended measures. Spine. 2000;25:3152.CrossRefPubMed
27.
Amick BC, Habeck RV, Ossmann J, Fossel AH, Keller R, Katz JN. Predictors of successful work role functioning after carpal tunnel release surgery. J Occup Environ Med. 2004;46:490–500.CrossRefPubMed
28.
Vercoulen JH, Swanink CM, Fennis JF, Galama JM, Van Der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38:383–92.CrossRefPubMed
29.
Beurskens AJ, Bültmann U, Kant I, Vercoulen J, Bleijenberg G, Swaen G. Fatigue among working people: validity of a questionnaire measure. J Occup Environ Med. 2000;57:353–7.CrossRef
30.
Manea L, Gilbody S, Mcmillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (Phq-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37:67–75.CrossRefPubMed
31.
Manea L, Gilbody S, Mcmillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (Phq-9): a meta-analysis. CMAJ. 2012;184:E191–6.CrossRefPubMedPubMedCentral
32.
Aaronson NK, Muller M, Cohen PD, Essink-Bot M, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the Sf-36 health survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055–68.CrossRefPubMed
33.
Terwee CB, Bot SDM, De Boer MR, Van Der Windt D, Knol D, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRefPubMed
34.
Breckenridge LM, Bruns GI, Tod B, Feuerstein M. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psychooncology. 2012;21:43–53.CrossRefPubMed
35.
Poppelreuter M, Weis J, Külz AK, Tucha O, Lange KW, Bartsch HH. Cognitive dysfunction and subjective complaints of cancer patients. A cross-sectional study in a cancer rehabilitation centre. Eur J Cancer. 2004;40:43–9.CrossRefPubMed
Metadata
Title
The Cognitive Symptom Checklist-Work in cancer patients is related with work functioning, fatigue and depressive symptoms: a validation study
Authors
H. F. Dorland
F. I. Abma
C. A. M. Roelen
A. Smink
M. Feuerstein
B. C. Amick
A. V. Ranchor
U. Bültmann
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0500-9

Other articles of this Issue 3/2016

Journal of Cancer Survivorship 3/2016 Go to the issue

OriginalPaper

The sexual health of female rectal and anal cancer survivors: results of a pilot randomized psycho-educational intervention trial

OriginalPaper

Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: the role of encoding versus forgetting

OriginalPaper

Higher-intensity exercise helps cancer survivors remain motivated

OriginalPaper

Medicaid expansion and access to care among cancer survivors: a baseline overview

OriginalPaper

Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse

OriginalPaper

Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits